51 studies found for:    Open Studies | "Keratosis, Actinic"
Show Display Options
Rank Status Study
21 Recruiting Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Balding Scalp Including 12-month Follow-up
Condition: Actinic Keratosis
Interventions: Drug: LEO 43204 gel;   Drug: Vehicle gel
22 Recruiting Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Face or Chest Including 12-month Follow-up
Condition: Actinic Keratosis
Interventions: Drug: LEO 43204 gel;   Drug: Vehicle gel
23 Recruiting Efficacy and Safety of LEO 43204 in the Field Treatment of Actinic Keratosis on Face or Chest including12-month Follow-up
Condition: Actinic Keratosis
Interventions: Drug: LEO 43204 gel;   Drug: Vehicle gel
24 Recruiting Clinical Trial of Ingenol Mebutate Gel 0.015% & 0.05% in Actinic Keratosis
Condition: Actinic Keratosis
Interventions: Drug: ingenol mebutate gel 0.015%;   Drug: ingenol mebutate gel 0.05%
25 Recruiting Ingenol Mebutate Gel 0.05% in Kidney Transplant Recipients With Actinic Keratoses
Condition: Actinic Keratosis
Intervention: Drug: ingenol mebutate 500 ucg
26 Recruiting Fractional Laser-assisted Daylight Photodynamic Therapy Versus Daylight Photodynamic for Treatment of Actinic Keratoses
Condition: Actinic Keratosis
Interventions: Procedure: Pretreatment with CO2 laser before photodynamic therapy;   Device: Only photodynamic therapy
27 Recruiting Bilateral Comparison of Treatment of Facial Actinic Keratoses Using Microneedling and Photodynamic Therapy With Aminolevulinic Acid and Blue Light Versus Photodynamic Therapy With Aminolevulinic Acid and Blue Light Using Two Incubation Times
Condition: Actinic Keratoses
Interventions: Drug: Aminolevulinic Acid (ALA);   Device: Environ Cosmetic Roller;   Device: BLU-U IIlluminator
28 Recruiting Maximal Use Systemic Exposure Study of Levulan Kerastick (MUSE 2)
Condition: Keratosis, Actinic
Interventions: Drug: Aminolevulinic Acid (ALA);   Device: BLU-U
29 Recruiting Microneedle Lesion Preparation Prior to ALA-PDT for AK on Face
Condition: Actinic Keratosis
Interventions: Drug: ALA;   Drug: Topical Solution Vehicle;   Device: IBL 10 mW;   Procedure: Microneedle lesion preparation;   Device: IBL 20 mW
30 Recruiting The Use of Microneedles to Expedite Treatment Time in Photodynamic Therapy
Condition: Keratosis, Actinic
Interventions: Device: Microneedle Roller;   Drug: Aminolevulinic Acid;   Radiation: Blue Light
31 Recruiting Eight Week Study of Treatment With DFD-07 for Actinic Keratosis of the Face and Scalp
Condition: Actinic Keratosis
Interventions: Drug: DFD-07 Cream;   Drug: Placebo Cream
32 Recruiting An Open-Label Safety Study of A-101 Solution
Condition: Seborrheic Keratosis
Intervention: Drug: A-101 Solution
33 Recruiting Daylight-PDT With MAL for AK and Photodamaged Skin
Conditions: Actinic Keratoses;   Photodamaged Skin
Interventions: Drug: Daylight photodynamic therapy using Methylaminolevulinate (MAL);   Procedure: Cryosurgery
34 Recruiting Risk of Squamous Cell Carcinoma on Skin Areas Treated With Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5%
Condition: Actinic Keratosis (AK)
Interventions: Drug: Ingenol Mebutate Gel, 0.015%;   Drug: Imiquimod Cream, 5%
35 Recruiting A Clinical Trial Evaluating the Role of Systemic Antihistamine Therapy in the Reduction of Adverse Effects Associated With Topical 5-aminolevulinic Acid Photodynamic Therapy
Condition: Actinic Keratoses
Interventions: Drug: Antihistamine Cetirizine Hydrochloride;   Other: Placebo
36 Recruiting PMS to Evaluate the Safety and Efficacy of Picato® Gel
Condition: Actinic Keratosis
Intervention: Drug: Ingenol mebutate 0.015 percent or 0.05 percent gel
37 Not yet recruiting Treatment of Field Cancerization for Reduction in Tumor Burden - A Prospective Study
Conditions: Extensive Photodamage;   Actinic Keratosis;   History of Numerous Skin Cancers
Interventions: Device: Ultrapulse Carbon Dioxide Laser;   Device: Cellutome epidermal harvesting system
38 Unknown  5fluorouracil for Advanced Photoaging
Conditions: Photoaging;   Actinic Keratosis
Interventions: Drug: 5-fluoruracil;   Procedure: 5-fluoruracil
39 Recruiting Potential Research Study Participant Registry
Conditions: Acne;   Actinic Keratosis;   Dysplastic Nevi;   Eczema;   Psoriasis;   Skin Cancer;   Rosacea;   Leg Ulcers;   Foot Ulcers;   Atopic Dermatitis
Intervention:
40 Recruiting Tobacco Cessation Intervention Study for Oral Diseases
Conditions: Smoking Cessation;   Mouth Diseases;   Periodontal Diseases;   Leukoplakia;   Lichen Planus;   Keratosis;   Implant
Intervention: Other: Tobacco cessation intervention

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-51) Show next page of results    Last Page
Indicates status has not been verified in more than two years